Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Liver Diseases

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 271 articles: HTML format Text format

Single Articles

February 2010
1. AKAZAWA Y , Cazanave S, Mott JL, Elmi N, et al
   Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. TOVAR V , Alsinet C, Villanueva A, Hoshida Y, et al
   IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. FUKUCHI Y , Furihata T, Hashizume M, Iikura M, et al
   Characterization of ribavirin uptake systems in human hepatocytes.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. MEJIAS M , Garcia-Pras E, Gallego J, Mendez R, et al
   Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LEE SS , Park SH, Kim HJ, Kim SY, et al
   Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
6. GERMANI G , Pleguezuelo M, Gurusamy K, Meyer T, et al
   Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SHERMAN M
   Serological Surveillance for hepatocellular carcinoma: Time to quit.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. TAN AT , Koh S, Goh W, Zhe HY, et al
   A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. NEUVEUT C , Wei Y, Buendia MA
   Mechanisms of HBV-related hepatocarcinogenesis.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. FRANCOZ C , Glotz D, Moreau R, Durand F, et al
    The evaluation of renal function and disease in patients with cirrhosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. BENGSCH B , Thimme R
    Ribavirin ante portas: Uptake transporters into hepatocytes dissected.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
12. CIUCLAN L , Ehnert S, Ilkavets I, Weng HL, et al
    TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. GLASER SS , Alpini G
    International Hepatology.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. YADAV SK , Srivastava A, Srivastava A, Thomas MA, et al
    Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. FORNER A , Bruix J
    Ablation for hepatocellular carcinoma: Is there need to have a winning technique?
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    December 2009
16. TAURA P , Fuster J, Mercadal J, Martinez-Palli G, et al
    The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. HUNG HH , Su CW, Wu JC, Lee SD, et al
    Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
18. JANSSEN MJ , Waanders E, Woudenberg J, Lefeber DJ, et al
    Congenital disorders of glycosylation in hepatology: The example of polycystic liver disease.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. GUIMARAES EL , Empsen C, Geerts A, van Grunsven LA, et al
    Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. FONTANA RJ
    Entecavir in decompensated HBV cirrhosis: The future is looking brighter.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
21. TESTRO AG , Gow PJ, Angus PW, Wongseelashote S, et al
    Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SHIM JH , Lee HC, Kim KM, Lim YS, et al
    Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. NAVARRO-ALVAREZ N , Soto-Gutierrez A, Chen Y, Caballero-Corbalan J, et al
    Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. BERNUAU J , Durand F
    Early prediction of encephalopathy in hospitalized patients with severe acute liver disease: the narrow window of opportunity for transplant-free survival.
    J Hepatol. 2009;51:977-80.
    PubMed     Text format     Related articles   
    
    
    
25. FORNER A , Trinchet JC
    Transarterial therapies in HCC: does embolization increase survival?
    J Hepatol. 2009;51:981-3.
    PubMed     Text format     Related articles   
    
    
    
26. SHERMAN M
    Vinyl chloride and the liver.
    J Hepatol. 2009;51:1074-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
27. JOUAN L , Melancon P, Rodrigue-Gervais IG, Raymond VA, et al
    Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. MANCONE C , Conti B, Amicone L, Bordoni V, et al
    Proteomic analysis reveals a major role for contact inhibition in the terminal differentiation of hepatocytes.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. HOEKSTRA M , Li Z, Kruijt JK, Eck MV, et al
    The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. GRASSO A
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: A clarification.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
31. WU KT , Yang JF, Chuang WL, Yu ML, et al
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
32. TERRIS B , Cavard C, Perret C
    EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. ABID A , Taha O, Nseir W, Farah R, et al
    Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
    J Hepatol. 2009;51:918-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. DOMART MC , Esposti DD, Sebagh M, Olaya N, et al
    Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy.
    J Hepatol. 2009;51:881-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MERLE U , Eisenbach C, Weiss KH, Tuma S, et al
    Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
    J Hepatol. 2009;51:925-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
36. AIHARA A , Tanaka S, Yasen M, Matsumura S, et al
    The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. WIEST R , Schoelmerich J
    Secondary peritonitis in cirrhosis: "Oil in fire"
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
38. HUYNH H , Ngo VC, Koong HN, Poon D, et al
    AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. KAO YH , Chen CL, Jawan B, Chung YH, et al
    Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SORIANO G , Castellote J, Alvarez C, Girbau A, et al
    Secondary bacterial peritonitis in cirrhosis: A retrospective study of clinical and analytical characteristics, diagnosis and management.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. MERKEL C , Bolognesi M, Berzigotti A, Amodio P, et al
    Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. CHEN KF , Yu HC, Liu TH, Lee SS, et al
    Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. NAKAMOTO S , Imazeki F, Fukai K, Fujiwara K, et al
    Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. COBBOLD JF , Patel JH, Goldin RD, North BV, et al
    Hepatic lipid profiling in chronic hepatitis C: An in vitro and in vivo proton magnetic resonance spectroscopy study.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. TSOCHATZIS EA , Gurusamy KS, Gluud C, Burroughs AK, et al
    Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
46. BEUERS U , Trauner M
    Ursodeoxycholic acid in primary biliary cirrhosis: Reply.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
47. DOMENICALI M , Caraceni P, Giannone F, Baldassarre M, et al
    A novel model of CCl(4)-induced cirrhosis with ascites in the mouse.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. OKUSAKA T , Kasugai H, Shioyama Y, Tanaka K, et al
    Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. TAKIKAWA Y , Endo R, Suzuki K, Tsubouchi H, et al
    Early prediction of short-term development of hepatic encephalopathy in patients with acute liver disease unrelated to paracetamol. A prospective study in Japan.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. MIELE L , Vallone S, Cefalo C, La Torre G, et al
    Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    J Hepatol. 2009;51:778-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. HOEKSTRA J , Leebeek FW, Plessier A, Raffa S, et al
    Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.
    J Hepatol. 2009;51:696-706.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
52. GUIU B , Loffroy R, Hillon P, Petit JM, et al
    Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: Urgent need for standardization!
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
53. UNZU C , Sampedro A, Mauleon I, Vanrell L, et al
    Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. HIRAGA N , Imamura M, Hatakeyama T, Kitamura S, et al
    Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. DASARATHY S , Dasarathy J, Khiyami A, Joseph R, et al
    Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. PARDO-SAGANTA A , Latasa MU, Castillo J, Alvarez-Asiain L, et al
    The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. HOSHIDA Y
    Risk of recurrence in hepatitis B-related hepatocellular carcinoma: Impact of viral load in late recurrence.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    August 2009
58. KOSTERS A , White DD, Sun H, Thevananther S, et al
    Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. PARK CY , Choi SH, Kang SM, Kang JI, et al
    Nonstructural 5A protein activates beta-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. CARRION JA , Navasa M, Forns X
    Antiviral therapy in HCV-infected cirrhotic patients awaiting liver transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
61. REIBERGER T , Angermayr B, Schwabl P, Rohr-Udilova N, et al
    Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. CHEW V , Tow C, Teo M, Wong HL, et al
    Inflammatory tumor microenvironment is associated with superior survival in hepatocellular carcinoma patients.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. MCPHERSON S , Jonsson JR, Cowin GJ, O'Rourke P, et al
    Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    J Hepatol. 2009;51:389-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. IMAMURA M , Tsutsui H, Yasuda K, Uchiyama R, et al
    Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice.
    J Hepatol. 2009;51:333-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. TORDJMAN J , Poitou C, Hugol D, Bouillot JL, et al
    Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.
    J Hepatol. 2009;51:354-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
66. WANG B , Trippler M, Pei R, Lu M, et al
    Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis c virus replication.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. GRASSO A , Malfatti F, Leo PD, Martines H, et al
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. WU JC , Huang YH, Chau GY, Su CW, et al
    Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. MOTTU A , Rubbia-Brandt L, Bihl F, Hadengue A, et al
    Acute hepatitis due to brivudin: A case report.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. KADAYIFCI A , Bass NM
    Coronary artery disease in NASH-related cirrhosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
71. MOSCHEN AR , Molnar C, Wolf AM, Weiss H, et al
    Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. MANOLAKOPOULOS S , Triantos C, Theodoropoulos J, Vlachogiannakos J, et al
    Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. KALAITZAKIS E , Bjornsson E
    Coronary artery disease in liver cirrhosis: Does the aetiology of liver disease matter?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
74. BAFFY G
    Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
    J Hepatol. 2009;51:212-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. RAUTOU PE , Angermayr B, Garcia-Pagan JC, Moucari R, et al
    Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes.
    J Hepatol. 2009;51:47-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
76. GARCIA-PAGAN JC , Valla DC
    Portal vein thrombosis: A predictable milestone in cirrhosis?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
77. BONORINO P , Ramzan M, Camous X, Dufeu-Duchesne T, et al
    Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. WRIGHT LM , Huster D, Lutsenko S, Wrba F, et al
    Hepatocyte GP73 expression in Wilson disease.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. MONTAGNESE S , Middleton B, Skene DJ, Morgan MY, et al
    Sleep-wake patterns in patients with cirrhosis: All you need to know on a single sheet A simple sleep questionnaire for clinical use.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. NIEMCZYK M , Krawczyk M, Paczek L
    Antiviral therapy preceding liver transplantation in HCV cirrhosis - Still too many doubts.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
81. NEWELL P , Toffanin S, Villanueva A, Chiang DY, et al
    Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. LI C , Kong Y, Wang H, Wang S, et al
    Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis.
    J Hepatol. 2009;50:1174-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. OKIYAMA W , Tanaka N, Nakajima T, Tanaka E, et al
    Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.
    J Hepatol. 2009;50:1236-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. BEDOSSA P , Carrat F
    Liver fibrosis: screening is not staging.
    J Hepatol. 2009;50:1268-9.
    PubMed     Text format     Related articles   
    
    
    
85. POYNARD T , Benhamou Y, Thabut D, Ratziu V, et al
    Liver biopsy: the best standard...when everything else fails.
    J Hepatol. 2009;50:1267-8.
    PubMed     Text format     Related articles   
    
    
    
86. SASAKAWA A , Tatsumi T, Takehara T, Yamaguchi S, et al
    Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment.
    J Hepatol. 2009;50:1155-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
87. PERUT V , Conti F, Scatton O, Soubrane O, et al
    Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease?
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. HOSHIDA Y
    Tumor-derived molecular information and outcome in hepatocellular carcinoma.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
89. CAZZANIGA M , Dionigi E, Gobbo G, Fioretti A, et al
    The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. KUBOKI S , Sakai N, Clarke C, Schuster R, et al
    The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. LA MURA V , Abraldes JG, Raffa S, Retto O, et al
    Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. BARTOSCH B , Thimme R, Blum HE, Zoulim F, et al
    Hepatitis C virus-induced hepatocarcinogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. TRIPODI A , Chantarangkul V, Primignani M, Dell'era A, et al
    Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INR(liver)) can help to implement the INR(liver) for the calculation of the MELD score.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. ZHANG S , Wang J, Liu Q, Harnish DC, et al
    Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. MERKEL C
    A short cut to predict the clinical response to beta-blocker therapy in cirrhosis?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
96. YOSHIJI H , Noguchi R, Toyohara M, Ikenaka Y, et al
    Combination of vitamin K(2) and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. SELMI C , Gershwin ME
    The retroviral myth of primary biliary cirrhosis: Is this (finally) the end of the story?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
98. KAKINUMA S , Ohta H, Kamiya A, Yamazaki Y, et al
    Analyses of cell surface molecules on hepatic stem/progenitor cells in mouse fetal liver.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. JIANG JX , Mikami K, Venugopal S, Li Y, et al
    Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. POGRIBNY IP , Tryndyak VP, Bagnyukova TV, Melnyk S, et al
     Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. KUDO H , Takahara T, Yata Y, Kawai K, et al
     Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. MOLLICA MP , Lionetti L, Moreno M, Lombardi A, et al
     3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. ARGO CK , Northup PG, Al-Osaimi AM, Caldwell SH, et al
     Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. CORTEZ-PINTO H , Machado MV
     Uncoupling proteins and non-alcoholic fatty liver disease.
     J Hepatol. 2009;50:857-60.
     PubMed     Text format     Related articles   
     
     
     
105. GIOVANNINI C , Gramantieri L, Chieco P, Minguzzi M, et al
     Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
     J Hepatol. 2009;50:969-79.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. JIN X , Yang YD, Chen K, Lv ZY, et al
     HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD.
     J Hepatol. 2009;50:1019-28.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. LI Y , Xu C, Yu C, Xu L, et al
     Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.
     J Hepatol. 2009;50:1029-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
108. GUEDJ N , Zhan Q, Perigny M, Rautou PE, et al
     Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. ZOCCO MA , Stasio ED, Cristofaro RD, Novi M, et al
     Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. WEGERT M , Monica NL, Tripodi M, Adler G, et al
     Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. TIEN YW , Wu YM, Lin WC, Lee HS, et al
     Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. CASTERA L , de Ledinghen V, Couzigou P
     Transient elastography vs. blood tests for the diagnosis of cirrhosis: An empiric victory.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
113. HU PF , Chen H, Zhong W, Lin Y, et al
     Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. TRAPPOLIERE M , Caligiuri A, Schmid M, Bertolani C, et al
     Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. PISCAGLIA AC , Shupe TD, Pani G, Tesori V, et al
     Establishment of cancer cell lines from rat hepatocholangiocarcinoma and assessment of the role of granulocyte-colony stimulating factor and hepatocyte growth factor in their growth, motility and survival.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. SNYKERS S , Henkens T, De Rop E, Vinken M, et al
     Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation, and stem cell reprogrammation.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. VINCIGUERRA M , Carrozzino F, Peyrou M, Carlone S, et al
     Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. FREEMAN RB , Jamieson N, Schaubel DE, Porte RJ, et al
     Who should get a liver graft?
     J Hepatol. 2009;50:664-73.
     PubMed     Text format     Related articles   
     
     
     
119. CLAVIEN PA
     Who should get a liver graft?
     J Hepatol. 2009;50:662-3.
     PubMed     Text format     Related articles   
     
     
     
120. MOHANTY SR , Troy TN, Huo D, O'Brien BL, et al
     Influence of ethnicity on histological differences in non-alcoholic fatty liver disease.
     J Hepatol. 2009;50:797-804.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. CROSWELL JM , Kramer BS
     Clinical trial design and evidence-based outcomes in the study of liver diseases.
     J Hepatol. 2009;50:817-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. KHANDOGA A , Huettinger S, Khandoga AG, Li H, et al
     Leukocyte transmigration in inflamed liver: A role for endothelial cell-selective adhesion molecule.
     J Hepatol. 2009;50:755-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. CABALLERO F , Fernandez A, De Lacy AM, Fernandez-Checa JC, et al
     Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.
     J Hepatol. 2009;50:789-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. COLLI A , Fraquelli M
     What is the actual role of diagnosis and how to assess it?
     J Hepatol. 2009;50:828-9.
     PubMed     Text format     Related articles   
     
     
     March 2009
125. ADORINI L
     Vitamin D receptor polymorphisms in primary biliary cirrhosis: A functional connection?
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
126. PANG M , de la Monte SM, Longato L, Tong M, et al
     PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. KARLSEN TH
     Genome-wide association studies reach hepatology.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. RAIMONDI S , Bruno S, Mondelli MU, Maisonneuve P, et al
     Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. MELLING N , Hohenberger W, Yedibela S
     Opisthorchiasis mimicking primary biliary cirrhosis as an indication for liver transplantation.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. HENRIKSEN JH , Moller S
     WITHDRAWN: Kowalski HJ, Abelmann WH. The cardiac output in Laennec's cirrhosis [J Clin Invest 1953;32:1025-1033].
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. BARTOSCH B
     Hepatitis C virus and its complex interplay with the hepatic glucose and lipid metabolism.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
132. FORNER A , Roayaie S
     Clinical research in hepatocellular carcinoma: Study design and endpoints.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
133. CALES P , Boursier J, Oberti F
     Ultrasonographic elastometry vs. blood tests for the diagnosis of cirrhosis: A Pyrrhic victory?
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
134. ZHANG JP , Yan J, Xu J, Pang XH, et al
     Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. NABESHIMA Y , Tazuma S, Kanno K, Hyogo H, et al
     Deletion of angiotensin II type I receptor reduces hepatic steatosis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. CHRISTENSEN E
     Portal hypertension and development of hepatocellular carcinoma: Factors influencing significance in prognostic models.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
137. SHERMAN M
     Prevention of hepatocellular carcinoma: The holy grail of hepatitis B treatment.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
138. SANSON E , Trautwein C
     Hepatocytes clear platelets and are key regulators of disseminated intravascular coagulation during sepsis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. LAI JP , Sandhu DS, Moser CD, Cazanave SC, et al
     Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. RIPOLL C , Groszmann RJ, Garcia-Tsao G, Bosch J, et al
     Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. FUJITA T
     Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
142. IZZEDINE H , Kheder-Elfekih R, Deray G, Thabut D, et al
     Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
143. HASEGAWA K , Makuuchi M, Kudo M, Okazaki M, et al
     Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma: Reply.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
144. TANAKA A , Nezu S, Uegaki S, Kikuchi K, et al
     Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. GRESSNER OA , Siluschek M, Lahme B, Gressner AM, et al
     Intraperitoneal application of caffeine prevents d-galactosamine induced hepatic expression of connective tissue growth factor (CTGF/CCN2) in the rat.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
146. FERNANDEZ M , Semela D, Bruix J, Colle I, et al
     Angiogenesis in liver disease.
     J Hepatol. 2009;50:604-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. BUTURA A , Nilsson K, Morgan K, Morgan TR, et al
     The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model.
     J Hepatol. 2009;50:572-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. BLOMME B , Van Steenkiste C, Callewaert N, Van Vlierberghe H, et al
     Alteration of protein glycosylation in liver diseases.
     J Hepatol. 2009;50:592-603.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. MINERVINI MI , Ruppert K, Fontes P, Volpes R, et al
     Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests.
     J Hepatol. 2009;50:501-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. SCHMIDT HH
     Role of genotyping in Wilson's disease.
     J Hepatol. 2009;50:449-52.
     PubMed     Text format     Related articles   
     
     
     
151. NICASTRO E , Loudianos G, Zancan L, D'Antiga L, et al
     Genotype-phenotype correlation in Italian children with Wilson's disease.
     J Hepatol. 2009;50:555-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
152. DIONISIO N , Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, et al
     Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. VLIEGEN I , Paeshuyse J, Burghgraeve TD, Lehman LS, et al
     Substituted imidazopyridines as potent inhibitors of HCV replication.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. TSAI MH , Peng YS, Chen YC, Lien JM, et al
     Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. LIU CJ , Lee PH, Lin DY, Wu CC, et al
     Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. KIM KA , Lin W, Tai AW, Shao RX, et al
     Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. MARTINELLI I , Primignani M, Aghemo A, Reati R, et al
     High levels of factor VIII and risk of extra-hepatic portal vein obstruction.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. STOCK H , Kadry Z, Smith JP
     Surgical management of portal hypertension in Felty's syndrome: A case report and literature review.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. SULKOWSKI M
     Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
160. ROCHE B , Samuel D
     Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
161. YIU WH , Pan CJ, Mead PA, Starost MF, et al
     Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. MARRERO JA
     Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.
     J Hepatol. 2009.
     PubMed     Text format     Related articles   
     
     
     
163. GUO CJ , Pan Q, Li DG, Sun H, et al
     miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. PIETRANGELO A
     Iron in NASH, chronic liver diseases and HCC: how much iron is too much?
     J Hepatol. 2009;50:249-51.
     PubMed     Text format     Related articles   
     
     
     
165. TSAI MC , Chen CH, Lee CM, Chen YT, et al
     The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.
     J Hepatol. 2009;50:281-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. CHANG Q , Zhang Y, Beezhold KJ, Bhatia D, et al
     Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer.
     J Hepatol. 2009;50:323-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
167. SAUTER D , Himmelsbach K, Kriegs M, Yepes MC, et al
     Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. ZENG S , Dun H, Ippagunta N, Rosario R, et al
     Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. SAMUEL D
     MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. YU B , Yang X, Xu Y, Yao G, et al
     Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
     Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. SALMON-CERON D , Rosenthal E, Lewden C, Bouteloup V, et al
     Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. FAN JG , Farrell GC
     Epidemiology of non-alcoholic fatty liver disease in China.
     J Hepatol. 2009;50:204-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. PARINI R , Furlan F, Notarangelo L, Spinazzola A, et al
     Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients.
     J Hepatol. 2009;50:215-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. VALLA DC
     Primary Budd-Chiari syndrome.
     J Hepatol. 2009;50:195-203.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. CALES P , Laine F, Boursier J, Deugnier Y, et al
     Comparison of blood tests for liver fibrosis specific or not to NAFLD.
     J Hepatol. 2009;50:165-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
177. KESHAVARZIAN A , Farhadi A, Forsyth CB, Rangan J, et al
     Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. CARRION JA , Martinez-Bauer E, Crespo G, Ramirez S, et al
     Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. ISHII H , Horie Y, Ohshima S, Anezaki Y, et al
     Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. DA SILVA MORAIS A , Lebrun V, Abarca-Quinones J, Brichard S, et al
     Prevention of steatohepatitis by pioglitazone: Implication of adiponectin-dependent inhibition of SREBP-1c and inflammation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. JOHAL H , Marie Scott G, Jones R, Camaris C, et al
     Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. FICKERT P , Trauner M
     When lightning strikes twice: The plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. WANG B , Feng P, Xiao Z, Ren EC, et al
     LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. LIN ZZ , Hsu HC, Hsu CH, Yeh PY, et al
     The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. DI TOMMASO L , Destro A, Seok JY, Balladore E, et al
     The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. SPENGLER U
     Hepatic microcirculation - A critical but neglected factor for the outcome of viral hepatitis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. BERG PA
     Autoimmunity in primary biliary cirrhosis: An alternative view at initiation and function of anti-mitochondrial autoantibodies.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
188. TIANI C , Garcia-Pras E, Mejias M, de Gottardi A, et al
     Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. CASTERA L , Forns X, Alberti A
     Interpreting liver stiffness in the cirrhotic range: What are we measuring?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
190. BIOULAC-SAGE P , Couffinhal T, Foucher J, Balabaud CP, et al
     Interpreting liver stiffness in the cirrhotic range.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
191. VOLK ML , Lok AS
     Is family history of liver cancer a risk factor for hepatocellular carcinoma?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
192. AHN J , Cho I, Kim S, Kwon D, et al
     Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet.
     J Hepatol. 2008;49:1019-28.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. NAHON P , Kettaneh A, Tengher-Barna I, Ziol M, et al
     Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
     J Hepatol. 2008;49:1062-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
194. CHEN L , Yan HX, Yang W, Hu L, et al
     The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. BERNAL W , Cross TJ, Auzinger G, Sizer E, et al
     Outcome after wait-listing for emergency liver transplantation in acute liver failure: A single centre experience.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. SORRENTINO P , D'Angelo S, Ferbo U, Micheli P, et al
     Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. BONEKAMP S , Kamel I, Solga S, Clark J, et al
     Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. LUYER MD , Derikx JP, Beyaert R, Hadfoune M, et al
     High-fat nutrition reduces hepatic damage following exposure to bacterial DNA and hemorrhagic shock.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. WEDEMEYER I , Bechmann LP, Odenthal M, Jochum C, et al
     Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. KANWAL F , El-Serag HB
     Hepatocellular cancer care: Cost is important but only one factor of disease burden.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
201. BOSCH J
     Towards the non-invasive diagnosis of cirrhosis: The nuts-cirrhosis connection.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
202. WERNER M , Almer S, Prytz H, Lindgren S, et al
     Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. MAHAJAN D , Miller C, Hirose K, McCullough A, et al
     Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
     J Hepatol. 2008;49:867-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
204. ANTONIADES CG , Berry PA, Wendon JA, Vergani D, et al
     The importance of immune dysfunction in determining outcome in acute liver failure.
     J Hepatol. 2008;49:845-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. TATSUMI T , Takehara T, Yamaguchi S, Sasakawa A, et al
     Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
     J Hepatol. 2008;49:779-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. KOMATSU M , Yazaki M, Tanaka N, Sano K, et al
     Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.
     J Hepatol. 2008;49:810-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
207. CASTERA L , Bail BL, Roudot-Thoraval F, Bernard PH, et al
     Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. STICKEL F , Droz S, Patsenker E, Bogli-Stuber K, et al
     Severe hepatotoxicity following ingestion of Herbalife((R)) nutritional supplements contaminated with Bacillus subtilis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. HASSAN MM , Spitz MR, Thomas MB, Curley SA, et al
     The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. JACOBS EM , Hendriks JC, van Deursen CT, Kreeftenberg HG, et al
     Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: The HEmochromatosis FAmily Study.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. YAMASHITA T , Honda M, Takatori H, Nishino R, et al
     Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. HO HK , Pok S, Streit S, Ruhe JE, et al
     Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. GACHE P , Hadengue A
     Baclofen improves abstinence in alcoholic cirrhosis: Still better to come?
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. ROSENBAUM J
     Vitamin A-guided siRNAs targeting a collagen chaperone can reverse experimental cirrhosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. BEUERS U , Oude-Elferink RP
     New light on anion exchangers in primary biliary cirrhosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
216. SAGMEISTER S , Drucker C, Losert A, Grusch M, et al
     HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. DIAZ-SANJUAN T , Garcia-Ruiz I, Rodriguez-Juan C, Munoz-Yague T, et al
     Interferon alpha increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent pathway in hepatic stellate cells.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. FUJITA T
     Probiotics for patients with liver cirrhosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
219. JASINGHE VJ , Xie Z, Zhou J, Khng J, et al
     ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. POUPON R , Ping C, Chretien Y, Corpechot C, et al
     Genetic factors of susceptibility and of severity in primary biliary cirrhosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. STADLBAUER V , Mookerjee RP, Jalan R
     Probiotics for patients with liver cirrhosis: Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
222. LANG K , Danchenko N, Gondek K, Shah S, et al
     The burden of illness associated with hepatocellular carcinoma in the United States.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. DE FRANCHIS R
     Non-invasive (and minimally invasive) diagnosis of oesophageal varices.
     J Hepatol. 2008;49:520-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
224. ONG JP , Pitts A, Younossi ZM
     Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
     J Hepatol. 2008;49:608-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. SOOKOIAN S , Pirola CJ
     Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.
     J Hepatol. 2008;49:600-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. BOOZARI B , Bahr MJ, Kubicka S, Klempnauer J, et al
     Ultrasonography in patients with Budd-Chiari syndrome: diagnostic signs and prognostic implications.
     J Hepatol. 2008;49:572-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
227. NIKKILA K , Nissinen MJ, Gylling H, Isoniemi H, et al
     Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. WEI Y , Liu D, Zhou F, Ge Y, et al
     Identification of beta-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. DE LIMA VM , Oliveira CP, Alves VA, Chammas MC, et al
     A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. RASKOPF E , Vogt A, Sauerbruch T, Schmitz V, et al
     siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. YUEN MF , Tanaka Y, Fong DY, Fung J, et al
     Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. CARMONA-CUENCA I , Roncero C, Sancho P, Caja L, et al
     Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. GALLE PR
     Sorafenib in advanced hepatocellular carcinoma - We have won a battle not the war.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. WEISSENBORN K
     PHES: one label, different goods?!
     J Hepatol. 2008;49:308-12.
     PubMed     Text format     Related articles   
     
     
     
235. MCKIERNAN PJ , Baumann U
     Neonatal classical galactosaemia presenting as citrin deficiency.
     J Hepatol. 2008;49:463.
     PubMed     Text format     Related articles   
     
     
     
236. ADERCA I , Moser CD, Veerasamy M, Bani-Hani AH, et al
     The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.
     J Hepatol. 2008;49:373-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. WADA S , Yamazaki T, Kawano Y, Miura S, et al
     Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice.
     J Hepatol. 2008;49:441-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. WEI Y , Clark SE, Morris EM, Thyfault JP, et al
     Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.
     J Hepatol. 2008;49:417-28.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
239. VRENKEN TE , Buist-Homan M, Kalsbeek AJ, Faber KN, et al
     The active metabolite of leflunomide, A77 1726, protects rat hepatocytes against bile acid-induced apoptosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. SWINKELS DW , Drenth JP
     Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
241. RAIMONDO G , Saitta C
     Treatment of the hepatitis B virus and hepatitis C virus co-infection: Still a challenge for the hepatologist.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
242. STOLZE LARSEN F
     Branched-chain amino acids antagonism in patients with cirrhosis and a simulated upper GI bleeding.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
243. PETROWSKY H , Busuttil RW
     Resection or ablation of small hepatocellular carcinoma: What is the better treatment?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
244. ZIPPRICH A , Loureiro-Silva MR, Jain D, D'Silva I, et al
     Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. SONG BJ , Moon KH, Olsson NU, Salem N Jr, et al
     Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids.
     J Hepatol. 2008;49:262-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
246. HENEGHAN MA , Selzner M, Yoshida EM, Mullhaupt B, et al
     Pregnancy and sexual function in liver transplantation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
247. CLAVIEN PA
     Liver transplantation for pregnancy-related liver diseases, pregnancy and sexual function after liver transplantation: What do we know?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
248. GUO X , Jin Y, Qian G, Tu H, et al
     Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
249. VIBERT E , Samuel D
     Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
250. CVEK B
     TNF-alpha could be responsible for disulfiram-mediated hepatotoxicity.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
251. IWAISAKO K , Hatano E, Taura K, Nakajima A, et al
     Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
252. RONCHETTI A , Prati D, Pezzotta MG, Tavian D, et al
     Severe steatohepatitis in a patient with a rare neutral lipid storage disorder due to an ABDH5 mutation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
253. TANAKA Y , Kanai F, Tada M, Tateishi R, et al
     Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
254. SELMI C , Zuin M, Eric Gershwin M
     The unfinished business of primary biliary cirrhosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. OTT M
     A symphony of techniques for liver cell therapy, only applicable to rats?
     J Hepatol. 2008;49:6-8.
     PubMed     Text format     Related articles   
     
     
     
256. TORGERSON PR , Schweiger A, Deplazes P, Pohar M, et al
     Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years.
     J Hepatol. 2008;49:72-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
257. DOUGLASS A , Wallace K, Parr R, Park J, et al
     Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.
     J Hepatol. 2008;49:88-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
258. MA X , Hua J, Li Z
     Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
259. KADAYIFCI A , Tan V, Ursell PC, Merriman RB, et al
     Clinical and pathologic risk factors for atherosclerosis in cirrhosis: A comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
260. BOGDANOS D , Pusl T, Rust C, Vergani D, et al
     Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. FLEMING KM , Aithal GP, Solaymani-Dodaran M, Card TR, et al
     Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: A general population-based study.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
262. KHURANA S , Mukhopadhyay A
     In vitro transdifferentiation of adult hematopoietic stem cells: An alternative source of engraftable hepatocytes.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. AFDHAL N , McHutchison J, Brown R, Jacobson I, et al
     Thrombocytopenia associated with chronic liver disease.
     J Hepatol. 2008;48:1000-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
264. MCCAUGHAN GW
     Adrenal insufficiency and liver disease - Re-search.
     J Hepatol. 2008;48:1018.
     PubMed     Text format     Related articles   
     
     
     
265. PAWLOTSKY JM
     Building a liver disease policy in the European Union.
     J Hepatol. 2008;48:889-91.
     PubMed     Text format     Related articles   
     
     
     
266. OUYANG X , Cirillo P, Sautin Y, McCall S, et al
     Fructose consumption as a risk factor for non-alcoholic fatty liver disease.
     J Hepatol. 2008;48:993-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2008
267. 
     Abstracts of the 43rd Annual Meeting of the European Association for the Study of the Liver, April 23-27, 2008, Milan, Italy.
     J Hepatol. 2008;48 Suppl 2:S1-375.
     PubMed     Text format     Related articles   
     
     
     
268. GIRARD M , Jacquemin E, Munnich A, Lyonnet S, et al
     miR-122, a paradigm for the role of microRNAs in the liver.
     J Hepatol. 2008;48:648-56.
     PubMed     Text format     Related articles    Abstract available
     
     
     
269. KALAMBOKIS G , Korantzopoulos P, Nikas SA, Theodorou A, et al
     Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment.
     J Hepatol. 2008;48:678-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
270. CINTRA DE , Pauli JR, Araujo EP, Moraes JC, et al
     Interleukin-10 is a protective factor against diet-induced insulin resistance in liver.
     J Hepatol. 2008;48:628-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2008
271. TOME S , Wells JT, Said A, Lucey MR, et al
     Quality of life after liver transplantation. A systematic review.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: